Advising clients on the in-licensing of trained machine learning models and associated software.
Advising clients on the development of internal guidelines for the use of AI, and generative AI in particular, related to privacy, data use and governance, and copyright law.
Advising clients on patent prosecution for AI-related inventions, including in the autonomous vehicles and life sciences spaces.
Advising technology companies on the impact of the disclosure of trade secrets to AI platforms.
Advising clients on AI platform contracts focusing specifically on indemnification provisions.
Advising clients on their industry information-sharing programs in light of DOJ and FTC concerns regarding the use of AI algorithms to foster collusion.
Advising on developing strategies and assessing pathways for obtaining FDA marketing authorization for software as a medical device with artificial intelligence / machine learning (AI / ML) functions.
Advising software developers on limiting certain AI / ML functions or claims relating to such functions to avoid classification as a medical device.
Advising clients on patent strategies when applying artificial intelligence to the discovery and development of therapeutics and to enhance diagnostics systems and patient care.
Advising clients in connection with the commercialization of their technology platforms and eventual sale.
Advising clients on the acquisition of AI platforms, due diligence support, and other transactional matters in the space.
Advising software and technology services companies in digital transformation projects, Canadian patent prosecution, licensing and distribution agreements, and negotiation of contracts with customers.
